SHWZ (Medicine Man Technologies) Long-Term Debt: $133.8 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHWZ Medicine Man Technologies Inc SHWZ
12 GF Score
Price $0.00
View Full Analysis

What is Medicine Man Technologies Long-Term Debt?

Medicine Man Technologies SHWZ -90.00% 12 Long-Term Debt is $133.8 Mil as of Jun. 2024. GuruFocus rates SHWZ with a GF Score™ of 12/100.

Medicine Man Technologies's Long-Term Debt for the quarter that ended in Jun. 2024 was $133.8 Mil.

Medicine Man Technologies's quarterly Long-Term Debt declined from Dec. 2023 ($153.3 Mil) to Mar. 2024 ($130.1 Mil) but then increased from Mar. 2024 ($130.1 Mil) to Jun. 2024 ($133.8 Mil).

Medicine Man Technologies's annual Long-Term Debt increased from Dec. 2021 ($97.5 Mil) to Dec. 2022 ($125.5 Mil) and increased from Dec. 2022 ($125.5 Mil) to Dec. 2023 ($153.3 Mil).

Medicine Man Technologies  (OTCPK:SHWZ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medicine Man Technologies Long-Term Debt Related Terms

Medicine Man Technologies Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medicine Man Technologies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicine Man Technologies Long-Term Debt Chart

Medicine Man Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 13.90 97.48 125.52 153.26

Medicine Man Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.86 150.88 153.26 130.12 133.81
SHWZ
12GF Score
Medicine Man Technologies Inc SHWZ
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $133.8 Mil mean?
Medicine Man Technologies (SHWZ) has a Long-Term Debt of $133.8 Mil as of Jun. 2024.
Is Medicine Man Technologies' Long-Term Debt too high?
Medicine Man Technologies' current Long-Term Debt is $133.8 Mil. Overall, Medicine Man Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicine Man Technologies' Long-Term Debt compare to HEWA and RDGT?
Medicine Man Technologies' Long-Term Debt of $133.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medicine Man Technologies's current Long-Term Debt is $133.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicine Man Technologies stock overvalued right now?
Medicine Man Technologies (SHWZ) has a current Long-Term Debt of $133.8 Mil. The current Long-Term Debt is $133.8 Mil. Medicine Man Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medicine Man Technologies (SHWZ), the current Long-Term Debt is $133.8 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicine Man Technologies Business Description

Address 865 N. Albion Street, Suite 300, Denver, CO, USA, 80220
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
12GF Score

Get the complete analysis for SHWZ

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price